The size of the High-Performance Liquid Chromatography market in North America was around USD 1.33 Billion in 2022. It is expected to grow at a CAGR of 5.2% to reach 1.71 billion by 2027.
The high sensitivity and precision of the HPLC technology, the expanding importance of HPLC tests in drug approvals, the growing use of hyphenated procedures, and rising pharmaceutical R&D spending are all driving this North American market's expansion. Other factors driving the market expansion include greater HPLC penetration, the growing popularity of LC-MS (liquid chromatography-mass spectrometry), increased use of HPLC in pharmaceuticals for quality control testing and manufacturing, faster results, and separation. The high-performance liquid chromatography (HPLC) test is a sophisticated and costly analytical technology frequently employed in food processing and the clinical diagnosis of diseases and disorders. In addition, it is utilized in the pharmaceutical industry for drug analysis, molecular separation, and environmental management.
Because of its high sensitivity and accuracy, HPLC is increasingly being used by law enforcement authorities to detect performance-enhancing substances in the urine, boosting the market growth. The government's increased investment in clinical research and medication discovery and the growing demand for HPLC in research operations are all driving the market's growth. Furthermore, technological improvements in HPLC procedures, such as the advent of exact HPLC systems, offer the industry a considerable opportunity. The HPLC method is utilized in various applications, including water purification, food processing, biotechnology, pharmaceuticals, and more.
HPLC is used in the pharmaceutical sector at all stages of drug research and development. It is used to subjectively and quantitatively analyze medicinal ingredients during the production process. Government intervention in food safety and environmental management and a growing focus on accurate diagnostics and acceptance of chromatographic techniques as a standard approach for verifying the validity and specificity of medication components are projected to fuel market expansion in the future.
The high cost of the equipment and a scarcity of qualified analysts are expected to limit the growth rate of the North American high-performance liquid chromatography market.
This research report on the North America HPLC Market has been segmented and sub-segmented into the following categories:
Geographically, the greatest share of the global HPLC market is predicted to come from North America. The increase in R&D funding, a growing number of preclinical activities by CROs and pharmaceutical companies, and the growing food and agricultural business in Canada are driving market expansion in this region. As a result, North America dominates the global HPLC market in terms of both value and volume. Developed healthcare infrastructure, an increase in the number of industries over time, a high adoption rate of technologically advanced products, an increase in healthcare expenditure, and expertise and research activities in the region are factors contributing to the market's growth in North America.
During the forecast period, the U.S. HPLC market is forecasted to account for the most significant share in the North American market. The United States' significant R&D spending is the key driver of this regional market expansion.
The Canadian HPLC market is estimated to showcase a healthy CAGR from 2022 to 2027. Canada's pharmaceutical solid industry contributes significantly to the high North American regional market share. To stay competitive in the market and acquire a competitive advantage over other players, players employ various techniques. Mergers and acquisitions, product launches, partnerships and collaborations, and regional expansion are a few of the vital market activities.
KEY MARKET PLAYERS:
A few of the noteworthy companies in the North American high-performance liquid chromatography market profiled in this report are Waters Corporation, Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific Inc., GE Healthcare, PerkinElmer Inc., Bio-Rad Laboratories Inc., Gilson Inc., Phenomenex Inc., and JASCO Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org